Member Info for maestro1

But but lambo what happened about the warrants.

3m so far exercised. L1 have so much left.

Any rise will be heavily sold.

Isnt this what you said just week ago, what utter joker..

Lambo back in.....

So far lambo is ahead in chess game taking his 50%, lets see. Finger biting time..

I recall polx last year when they were suppose to release in morning, news came in afternoon of rejection.

News would have definately been released yesterday, fda given written notice if they dont meet targets.

Hope lambo doesnt hav last laugh and say i told u so.

Why would they do this, sellers will be pi's

Usa are 6/7 hours behind us, so imm would have been told yesterday evening uk time.

Lets wait..

Lambo u talkin about yourself..

Depends whag time they get results if they get at the end of the day, thats 9pm our time, we will have to get our rns approved by nomads etc so might be afternoon tomorrow, who knows but fun times for sure..

one bad quarter and this falls heavy what a crap storm from MM, should have sold at 170p.

maidit308

thats a very interesting article, we have agl recently got fda approved for breast cancer, they have no partner and had to raise cash recently.

IMM already having a large pharma funding phase 3 and bringing the drug into production is great, the mkt hasnt grasp this.

Avion looked at all the data from last trial and still took investment in company and decided to fund the whole phase 3.

IMM are cheap, but first we need phase 3 approval next week.. Its time for IMM to recover...

maidit308

Monday afternoon they will receive the PK study verdict, its bank holiday so verdict will release to mkt on tues.

not difficult..

Likely be tuesday.

Phase 3 here we come...

Lupozor has a "Benign safety profile", in that it is safe and no danger in side effect profile for patients.

Madeit

When fda set a date they genuinely on time if they are not they let the company know beforehand. So 29th aug is dead on..

"ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, is delighted to provide an update on the Lupuzor™ pharmacokinetic ("PK") study, as part of the new optimised international Phase 3 trial of Lupuzor™ in Lupus patients."

Last time they didnt ask for pk study to commence phase 3 but in the presentatiom they said it needs to be done before fda approval of drug.

Company is calling lupuzor a late stage phase 3 drug, so dont know why fda will ask for phase 2.

Seen many phase 2 drugs valued alot higher in usa, in tune of over$100m.

Lambo

You dont hav any shares invested here, stop lying..

Lambo, your full of it, you were ramping you sold and now you comfortable to deramp.

Avion have agreed optimised protocol with fda to test drug on patients with biomarkers, so why would fda change mind and tell them to go back to phase 1, what planet are you from?

Still laughin at your theory on options and warrants, you also fail to take into acc for all options/warrants it adds pounds to imm bank balance.

We will get feedback of the pk study data and will find out ifwe can go ahead with phase 3.

Placing flippers are gone, placing was £950k. So small.

So lets get this straight, l1 will buy 50m options at 5p and sell at 7.5p, to make £1.25m profit. Why would they do this as phase 3 is gonna take 2 years and history shows sp will be over 25p by the time we get midway through phase 3 trials.?

So what is better £10m profit or £1.25m.

You are loony, you made your quick bucks and now you deramping..